Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Stud Health Technol Inform ; 298: 24-28, 2022 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-36073450

RESUMEN

The Digital Health Leadership Programme is commissioned by Health Education England and part of the wider NHS Digital Academy. The Programme is a consortium of Imperial College London's Institute of Global Health Innovation, The University of Edinburgh's Usher Institute and Harvard Medical School. In 2021, Health Data Research UK joined Imperial and Edinburgh to deliver phase 2. The aim is to develop a new generation of digital health leaders to drive transformation of the NHS through digitisation. Participants gain the skills and knowledge to create change so that patient care and organisational operations can benefit from the many improvements and innovations modern technology has to offer.


Asunto(s)
Liderazgo , Medicina Estatal , Academias e Institutos , Salud Global , Promoción de la Salud , Humanos
2.
Health Aff (Millwood) ; 35(2): 301-8, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26858384

RESUMEN

Every year around fourteen million people globally are infected with human papillomavirus (HPV), the sexually transmitted virus that is the cause of most cervical cancers. A number of vaccines have been developed to protect against HPV, but in many countries, HPV vaccination rates have been low compared with rates for other recommended vaccines. Parental concerns, cost, and lack of information and awareness among both health professionals and parents are cited as important barriers to HPV vaccination. In Argentina the HPV vaccine has been provided to all eleven-year-old girls since 2011 as part of a comprehensive national program to prevent cervical cancer. Coverage increased from negligible levels before 2011 to a national average of 87.9 percent for the first dose, 71.6 percent for the second dose, and 52.2 percent for the third dose in 2013. There was a large variance in HPV vaccine coverage across the country's provinces. This article describes key strategies to overcome barriers to implementation of HPV vaccination and provides recommendations for policy makers.


Asunto(s)
Atención a la Salud/organización & administración , Promoción de la Salud , Programas de Inmunización/organización & administración , Programas Nacionales de Salud , Argentina , Niño , Difusión de Innovaciones , Femenino , Humanos , Estudios de Casos Organizacionales , Infecciones por Papillomavirus/economía , Infecciones por Papillomavirus/prevención & control , Vacunas contra Papillomavirus/economía , Neoplasias del Cuello Uterino/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA